Amphibious entrepreneurs and the emergence of organizational forms

Strategic Entrepreneurship Journal

Volumn 6, Issue 2, 2012, Pages 94-115

  Powell, Walter W ^a   Sandholtz, Kurt W ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Emergence; Imprinting; Models of organizing; Recombination; Transposition

Indexed keywords

EID: 84867380442     PISSN: 19324391     EISSN: 1932443X     Source Type: Journal    
DOI: 10.1002/sej.1129     Document Type: Article

References (109)

1. Audretsch D, Stephan P. 1996. Company-scientist locational links: the case of biotechnology. American Economic Review 86(3): 630-640.
2. Baker T, Nelson RE. 2005. Creating something from nothing: resource construction through entrepreneurial bricolage. Administrative Science Quarterly 50(3): 329-366.
3. Baron JN, Hannan MT, Burton MD. 1999. Building the iron cage: determinants of managerial intensity in the early years of organizations. American Sociological Review 64(4): 527-547.
4. Becker HS. 1963. Outsiders: Studies in the Sociology of Deviance. Free Press: Glencoe, IL.
5. Becker HS. 1986. Doing Things Together. Northwestern University Press: Evanston, IL.
6. Beckman CM, Burton MD. 2008. Founding the future: path dependence in the evolution of top management teams from founding to IPO. Organization Science 19(1): 3-24.
7. Benacerraf B. 1998. From Caracas to Stockholm: The Life in Medical Science. Prometheus: Amherst, NY.
8. Berman EP. 2007. Creating the market university: science, the state, and the economy, 1965-1985. Unpubished PhD dissertation, University of California, Berkeley.
9. Blumer H. 1969. Symbolic Interactionism: Perspective and Method. Prentice Hall: Englewood Cliffs, NJ.
10. Boyer HW. 2001. Herbert W. Boyer: recombinant DNA research at UCSF and commercial application at Genentech. Oral history conducted in 1994 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
11. Breiger RL. 1974. The duality of persons and groups. Social Forces 53: 181-190.
12. Burt RS. 2009. Neighbor Networks: Competitive Advantage Local and Personal. Oxford University Press: Oxford, U.K.
13. Burton MD, Sorensen JB, Beckman C. 2002. Coming from good stock: career histories and new venture formation. In Research in the Sociology of Organizations (Vol. 19), Lounsbury M, Ventresca M (eds). JAI Press: Greenwich, CT; 229-262.
14. Byers B. 2006. Brook Byers: biotechnology venture capitalist, 1970-2006. Oral history conducted in 2002-2005 by Thomas D. Kiley, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
15. Cape R. 2006. Ronald Cape: biotech pioneer and cofounder of CETUS. Oral history conducted in 2003 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
16. Chang D. 2009. What defines Genentech: money or mission? San Francisco Chronicle, 25 March.
17. Chatterji AK. 2009. Spawned with a silver spoon? Entrepreneurial performance and innovation in the medical device industry. Strategic Management Journal 30(2): 185-206.
18. Cockburn IM, Stern S. 2010. Finding the endless frontier: lessons from the life sciences innovation system for technology policy. Capitalism and Society 5(1): article 1.
19. Cohen J. 1992. A power primer. Psychological Bulletin 112(1): 155-159.
20. Cohen SN, Chang ACY, Boyer HW Helling RB. 1973. Construction of biologically functional bacterial plasmids in vitro. Proceedings of the National Academy of Sciences 70: 3240-3244.
21. Curwood S. 1983. Biotech firm favors low end of market: integrated shuns glamour drugs. The Boston Globe, 20 December.
22. Daft RL, Lewin AY. 1990. Can organization studies begin to break out of the normal science straitjacket? An editorial essay. Organization Science 1(1): 1-9.
23. D'Andrade HA. 2001. Hugh D'Andrade: regional characteristics of biotechnology in the United States: perspectives of three industry leaders. Oral history conducted in 1998 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
24. Dietrich H. 2003. Amgen shrinks Seattle operations. Los Angeles Business Journal, 5 May.
25. Duncan DE. 2005. The Amgen Story: 25 Years of Visionary Science and Powerful Medicine. Tehabi Books: San Diego, CA.
26. Eisenhardt KM. 1989. Making fast strategic decisions in high-velocity environments. Academy of Management Journal 32(3): 543-576.
27. Eisenhardt KM, Graebner ME. 2007. Theory building from cases: opportunities and challenges. Academy of Management Journal 50(1): 25-32.
28. Feder BJ. 1992. Biogen seeks profits to call its own. The New York Times, 15 August: 31.
29. Finch H. 2005. Comparison of distance measures in cluster analysis with dichotomous data. Journal of Data Science 3(1): 85-100.
30. Fox J. 2000. Two patent disputes settled. Nature Biotechnology 18: 7.
31. Freeman J, Carroll CR, Hannan MT. 1983. The liability of newness: age dependence in organizational death rates. American Sociological Review 48(5): 692-710.
32. Froelich W. 1984. Biotech: area may be a new mecca. The San Diego Union, 23 January.
33. Fujimura JH. 1987. Constructing 'do-able' problems in cancer research: articulating alignment. Social Studies of Science 17(2): 257-293.
34. Gannes S. 1987. Striking it rich in biotech. Fortune, 9 November: 9.
35. GCL. 2012. American men and women of science. Gale Cengage Learning Available at: http://www.gale-edit.com/amws/index.htm (accessed 26 March 2012).
36. Glaser D. 2006. Donald Glaser: the bubble chamber, bioengineering, business consulting, and neurobiology. Oral history conducted in 2003-2004 by Eric Vettel, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
37. Greenwood R, Miller D. 2010. Tackling design anew: getting back to the heart of organizational theory. Academy of Management Perspectives 24(4): 78-88.
38. Hall SS. 1987. Invisible Frontiers: The Race to Synthesize a Human Gene. Atlantic Monthly Press: Boston, MA.
39. Hargadon AB, Douglas JY. 2001. When innovations meet institutions: Edison and the design of the electric light. Administrative Science Quarterly 46: 476-501.
40. Helfat CE, Lieberman MB. 2002. The birth of capabilities: market entry and the importance of pre-history. Industrial and Corporate Change 11(4): 725-760.
41. Higgins M. 2005. Career Imprints: How the Baxter Boys Built the Biotech Industry. John Wiley: San Francisco, CA.
42. Hilts PJ. 1981. The gold rush of companies into biotechnology is waning. The Washington Post, 3 November: A1.
43. Hounshell D. 1984. From the American System to Mass Production, 1800-1932. Johns Hopkins University Press: Baltimore, MD.
44. Hughes SS. 2001. Making dollars out of DNA: the first major patent in biotechnology and the commercialization of molecular biology, 1974-1980. Isis 92(3): 541-575.
45. Hughes SS. 2011. Genentech: The Beginnings of Biotech. University of Chicago Press: Chicago, IL.
46. Hybels RC. 1994. Legitimation, population density, and founding rates: the institutionalization of commercial biotechnology in the U.S., 1971-89. Unpublished PhD dissertation, Cornell University.
47. Johnson V. 2007. What is organizational imprinting? Cultural entrepreneurship in the founding of the Paris Opera. American Journal of Sociology 113(1): 97-127.
48. Jones MP. 2005. Biotech's perfect climate: the hybritech story. Unpublished PhD dissertation, University of California, San Diego.
49. Jong S. 2008. Academic organizations and new industrial fields: Berkeley and Stanford after the rise of biotechnology. Research Policy 37: 1267-1282.
50. Kaplan S, Murray F. 2010. Entrepreneurship and the construction of value in biotechnology. In Research in the Sociology of Organizations (Vol. 29), Phillips N, Sewell G, Griffiths D (eds). Emerald Group Publishing: Bingley, K.; 107-147.
51. Kaplan S, Tripsas M. 2008. Thinking about technology: applying a cognitive lens to technical change. Research Policy 37(5): 790-805.
52. Kauffman S. 2000. Investigations. Oxford University Press: New York.
53. Kenney M. 1986a. Schumpeterian innovation and entrepreneurs in capitalism: the case of the U.S. biotechnology industry. Research Policy 15(4): 21-31.
54. Kenney M. 1986b. Biotechnology: The University-Industrial Complex. Yale University Press: New Haven, CT.
55. Kiley TD. 2002. Thomas D. Kiley: Genentech legal counsel and vice president, 1976-1988, and entrepreneur. Oral history conducted in 2000 and 2001 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
56. Kornberg A. 1998. Arthur Kornberg: biochemistry at Stanford, biotechnology at DNAX. Oral history conducted in 1997 by Sally Smith Hughes, Ph.D., Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
57. Krackhardt D, Stern RN. 1988. Informal networks and organizational crises: an experimental simulation. Social Psychology Quarterly 51: 123-140.
58. Lerner M. 1987. Molecular genetics seeks fresh start: new CEO hopes to break chain of disappointments. Minneapolis-St. Paul Star Tribune, 21 September.
59. Lewis M. 2003. Moneyball: The Art of Winning an Unfair Game. Norton: New York.
60. Liu CC, Stuart TE. 2011. Boundary spanning in a for-profit research lab. Working paper, 11-012, Harvard Business School.
61. March JG, Simon HA. 1958. Organizations. John Wiley and Sons: New York.
62. McKelvey MD. 1996. Evolutionary Innovations: The Business of Biotechnology. Oxford University Press: Oxford, U.K.
63. McKendrick DG, Jaffee J, Carroll GR, Khessina OM. 2003. In the bud? Disk array producers as a (possibly) emergent organizational form. Administrative Science Quarterly 48(1): 60-93.
64. Mead GH. 1934. Mind, Self, and Society. University of Chicago Press: Chicago, IL.
65. Miles MB, Huberman AM. 1984. Qualitative Data Analysis: A Sourcebook of New Methods. SAGE Publications: Beverly Hills, CA.
66. Miner AS, Bassoff P, Moorman C. 2001. Organizational improvisation and learning: a field study. Administrative ScienceQuarterly 46(2): 304-337.
67. Mitton DG. 1990. Bring on the clones: a longitudinal study of the proliferation, development, and growth of the biotech industry in San Diego. In Frontiers of Entrepreneurship Research Churchill NC, Bygrave WD, Hornaday JA, Muzyka DF, Vesper KH, Wetzel WE Jr (eds). Babson College: Babson Park, MA; 344-358.
68. Nelson AJ. 2007. Institutional convergence and the diffusion of university- versus firm-origin technologies. Unpublished PhD dissertation, Stanford University.
69. Nelson RR, Winter SG. 1982. An Evolutionary Theory of Economic Change. Harvard University Press: Cambridge, MA.
70. Oliver AL, Montgomery K. 2000. Creating a hybrid organizational form from parental blueprints: the emergence and evolution of knowledge firms. Human Relations 53: 33-56.
71. Orsenigo L. 1989. The Emergence of Biotechnology: Institutions and Markets in Industrial Innovation. Pinter: London, U.K.
72. Owen-Smith J, Powell WW. 2004. Knowledge networks as channels and conduits: the effect of spillovers in the Boston biotechnology community. Organization Science 15(1): 5-21.
73. Padgett JF, McLean P. 2006. Organizational invention and elite transformation: the birth of partnership in Renaissance Florence. American Journal of Sociology 111(4): 1463-1568.
74. Penhoet E. 2001. Edward E. Penhoet: regional characteristics of biotechnology in the United States: perspectives of three industry leaders. Oral history conducted in 1998 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
75. Perkins TJ. 2002. Kleiner Perkins: venture capital, and the chairmanship of Genentech, 1976-1995. Oral history conducted in 2001 by Glenn E. Bugos, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
76. Phillips D. 2002. A genealogical approach to organizational life chances. Administrative Science Quarterly 47: 474-506.
77. Pisano G. 2006. Science Business: The Science, Reality, and Future of Biotech. Harvard Business School Press: Boston, MA.
78. Porter KA. 2004. You can't leave your past behind: the influence of founders' career histories on their firms. Unpublished PhD dissertation, Stanford University.
79. Powell WW. 1996. Inter-organizational collaboration in the biotechnology industry. Journal of Institutional and Theoretical Economics 120(1): 197-215.
80. Powell WW, Koput K, Smith-Doerr L. 1996. Technological change and the locus of innovation: networks of learning in biotechnology. Administrative Science Quarterly 41(1): 116-145.
81. Powell WW, White DR, Koput K, Owen-Smith J. 2005. Network dynamics and field evolution: the growth of interorganizational collaboration in the life sciences. American Journal of Sociology 110(4): 1132-1205.
82. Rabinow P. 1996. Making PCR: A Story of Biotechnology. University of Chicago Press: Chicago, IL.
83. Rathmann GB. 2004. George B. Rathmann: chairman, CEO, and president of Amgen, 1980-1988. Oral history conducted in 2003 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
84. Rawlings CM, Bourgeois MD. 2004. The complexity of institutional niches: credentials and organizational differentiation in a field of U.S. higher education. Poetics 32: 411-446.
85. Robb C. 1981. The business of life. The Boston Globe, 22 February.
86. Robbins-Roth C. 2000. From Alchemy to IPO. Perseus Publishing: Cambridge, MA.
87. Ruef M. 2000. The emergence of organizational forms: a community ecology approach. American Journal of Sociology 106(3): 658-714.
88. Ruef M. 2010. The Entrepreneurial Group. Princeton University Press: Princeton, NJ.
89. Santos F, Eisenhardt KM. 2009. Constructing markets and shaping boundaries: entrepreneurial agency in nascent fields. Academy of Management Journal 52(4): 643-671.
90. Saxenian A. 1994. Regional Advantage. Harvard University Press: Cambridge, MA.
91. Shane S, Stuart TE. 2002. Organizational endowments and the performance of university start-ups. Management Science 48(1): 154-170.
92. Simon HA. 1982. The architecture of complexity. Proceedings of the American Philosophical Society 106(6): 467-482.
93. Stinchcombe AL. 1965. Social structure and organizations. In Handbook of Organizations, March JG (ed). Rand McNally: Chicago, IL; 142-193.
94. Strauss A. 1978. Negotiations: Varieties, Contexts, Processes, and Social Order. Jossey-Bass: San Francisco, CA.
95. Stuart T, Sorenson O. 2003. Liquidity events and the geographic distribution of entrepreneurial activity. Administrative Science Quarterly 48(2): 175-201.
96. Swanson RA. 2001. Robert A. Swanson: cofounder, CEO, and chairman of Genentech, Inc., 1976-1996. Oral history conducted in 1996 and 1997 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
97. Tan P-N, Steinbach M, Kumar V. 2005. Introduction to Data Mining. Addison Wesley: Boston, MA.
98. Teitelman R. 1989. Gene Dreams: Wall Street, Academia, and the Rise of Biotechnology. Basic Books: New York.
99. Tripsas M. 2009. Technology, identity, and inertia through the lens of the digital photography company. Organization Science 20(2): 441-460.
100. Ullrich A. 2006. Alex Ullrich: molecular biologist at UCSF and Genentech. Oral history conducted in 1994 and 2003 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California, Berkeley.
101. Vaughan R. 2000. Listen to the Music: The Life of Hilary Koprowski. Springer-Verlag: New York.
102. Vedres B, Stark D. 2010. Structural folds: generative disruption in overlapping groups. American Journal of Sociology 115(4): 1150-1190.
103. Vettel EJ. 2006. Biotech: The Countercultural Origins of an Industry. University of Pennsylvania Press: Philadelphia, PA.
104. Wellman B, Berkowitz SD. 1988. Social Structures: A Network Approach. Cambridge University Press: Cambridge, U.K.
105. White HC. 2008. Identity and Control (2nd edn). Princeton University Press: Princeton, NJ.
106. Whittington KB, Owen-Smith J, Powell WW. 2009. Networks, propinquity, and innovation in knowledge-intensive industries. Administrative Science Quarterly 54(1): 90-122.
107. Wilson D, Heath D. 2001. No wonder they call the place 'Mother Hutch.' The Seattle Times, 14 March.
108. Wright S. 1994. Molecular Politics. University of Chicago Press: Chicago, IL.
109. Zucker LG, Darby MR. 1996. Star scientists and institutional transformation: patterns of invention and innovation in the formation of the biotechnology industry. Proceedings of the National Academy of Sciences 93: 12709-12716.